← Open Payments lookup

VLADISLAV YEGANOV: Open Payments

NPI 1538145792 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,524 in 183 payments from 17 companies in 2025. Trend: 2023 $2,828 · 2024 $3,404 · 2025 $3,524

Food & beverage: $3,524
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.43$966
Axsome Therapeutics, Inc.25$398
Teva Pharmaceuticals USA, Inc.14$329
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$259
Vanda Pharmaceuticals Inc.11$256
Janssen Pharmaceuticals, Inc12$231
E.R. Squibb & Sons, L.L.C.12$189
Alkermes, Inc.9$179
Avadel CNS Pharmaceuticals, LLC10$170
Corium, LLC10$167

Products named: INGREZZA, AUSTEDO XR, Sunosi, CAPLYTA, FANAPT, INVEGA SUSTENNA, COBENFY, ARISTADA.

Industry payments across TX — which companies pay providers there.